Serum Biomarkers and Their Association with Myocardial Function and Exercise Capacity in Cardiac Transthyretin Amyloidosis.

IL-6 MCP-1 atrial strain cardiac amyloidosis hsCRP inflammation klotho transthyretin amyloidosis ventricular strain

Journal

Journal of cardiovascular development and disease
ISSN: 2308-3425
Titre abrégé: J Cardiovasc Dev Dis
Pays: Switzerland
ID NLM: 101651414

Informations de publication

Date de publication:
30 Apr 2024
Historique:
received: 19 03 2024
revised: 21 04 2024
accepted: 29 04 2024
medline: 24 5 2024
pubmed: 24 5 2024
entrez: 24 5 2024
Statut: epublish

Résumé

Transthyretin cardiac amyloidosis (ATTR amyloidosis) is a frequent etiology of heart failure. Inflammation and mineral metabolism are associated with myocardial dysfunction and clinical performance. Cardiac global longitudinal strain (GLS) allows function assessment and is associated with prognosis. Our aim was to describe possible correlations between GLS, biomarker levels and clinical performance in ATTR amyloidosis. Thirteen patients with ATTR amyloidosis were included. Clinical characteristics; echocardiographic features, including strain assessment and 6 min walk test (6MWT); and baseline inflammatory, mineral metabolism and cardiovascular biomarker levels were assessed. Of the 13 patients, 46.2% were women, and the mean age was 79 years. TAPSE correlated with NT-ProBNP (r -0.65, While inflammatory biomarkers were correlated with cardiac function, klotho levels were associated with clinical performance in the population with TTR-CA.

Sections du résumé

BACKGROUND BACKGROUND
Transthyretin cardiac amyloidosis (ATTR amyloidosis) is a frequent etiology of heart failure. Inflammation and mineral metabolism are associated with myocardial dysfunction and clinical performance. Cardiac global longitudinal strain (GLS) allows function assessment and is associated with prognosis. Our aim was to describe possible correlations between GLS, biomarker levels and clinical performance in ATTR amyloidosis.
METHODS METHODS
Thirteen patients with ATTR amyloidosis were included. Clinical characteristics; echocardiographic features, including strain assessment and 6 min walk test (6MWT); and baseline inflammatory, mineral metabolism and cardiovascular biomarker levels were assessed.
RESULTS RESULTS
Of the 13 patients, 46.2% were women, and the mean age was 79 years. TAPSE correlated with NT-ProBNP (r -0.65,
CONCLUSIONS CONCLUSIONS
While inflammatory biomarkers were correlated with cardiac function, klotho levels were associated with clinical performance in the population with TTR-CA.

Identifiants

pubmed: 38786964
pii: jcdd11050142
doi: 10.3390/jcdd11050142
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Instituto de Salud Carlos III
ID : PI19/00655
Organisme : Instituto de Salud Carlos III
ID : PI20/0923
Organisme : European Union Horizon 2020
ID : 819775
Organisme : Spanish Ministry of Science and Innovation
ID : RTC2019-006826-1
Organisme : Spanish Ministry of Science and Innovation
ID : PID2019-107332RB-I00

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Auteurs

Luis Nieto-Roca (L)

Department of Cardiology, IIS-Fundación Jiménez Díaz University Hospital-Quironsalud, Avenida Reyes Católicos, 2, 28040 Madrid, Spain.
Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Melchor Fernández Almagro, 3, 28029 Madrid, Spain.

Andrea Camblor Blasco (A)

Department of Cardiology, IIS-Fundación Jiménez Díaz University Hospital-Quironsalud, Avenida Reyes Católicos, 2, 28040 Madrid, Spain.
Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Melchor Fernández Almagro, 3, 28029 Madrid, Spain.

Ana Devesa (A)

Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Melchor Fernández Almagro, 3, 28029 Madrid, Spain.
Zena and Michael A. Weiner Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Sandra Gómez-Talavera (S)

Department of Cardiology, IIS-Fundación Jiménez Díaz University Hospital-Quironsalud, Avenida Reyes Católicos, 2, 28040 Madrid, Spain.
Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Melchor Fernández Almagro, 3, 28029 Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain.

Jorge Balaguer-Germán (J)

Department of Cardiology, IIS-Fundación Jiménez Díaz University Hospital-Quironsalud, Avenida Reyes Católicos, 2, 28040 Madrid, Spain.

Jairo Lumpuy-Castillo (J)

Laboratory of Diabetes and Vascular Pathology, IIS-Fundación Jiménez Díaz, Medicine Department, Universidad Autónoma, 28040 Madrid, Spain.
Spanish Biomedical Research Centre on Diabetes and Associated Metabolic Disorders (CIBERDEM) Network, 28040 Madrid, Spain.

Ana María Pello (AM)

Department of Cardiology, IIS-Fundación Jiménez Díaz University Hospital-Quironsalud, Avenida Reyes Católicos, 2, 28040 Madrid, Spain.

Luis Martínez Dhier (LM)

Department of Nuclear Medicine, IIS-Fundación Jiménez Díaz University Hospital-Quironsalud, Av. Reyes Católicos, 2, 28040 Madrid, Spain.

Gregoria Lapeña (G)

Department of Nuclear Medicine, IIS-Fundación Jiménez Díaz University Hospital-Quironsalud, Av. Reyes Católicos, 2, 28040 Madrid, Spain.

Lucía Llanos Jiménez (LL)

Research Unit, IIS-Fundación Jiménez Díaz, 28002 Madrid, Spain.

Óscar Lorenzo (Ó)

Laboratory of Diabetes and Vascular Pathology, IIS-Fundación Jiménez Díaz, Medicine Department, Universidad Autónoma, 28040 Madrid, Spain.
Spanish Biomedical Research Centre on Diabetes and Associated Metabolic Disorders (CIBERDEM) Network, 28040 Madrid, Spain.

José Tuñón (J)

Department of Cardiology, IIS-Fundación Jiménez Díaz University Hospital-Quironsalud, Avenida Reyes Católicos, 2, 28040 Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain.
Faculty of Medicine, Universidad Autónoma de Madrid, 28029 Madrid, Spain.

Borja Ibáñez (B)

Department of Cardiology, IIS-Fundación Jiménez Díaz University Hospital-Quironsalud, Avenida Reyes Católicos, 2, 28040 Madrid, Spain.
Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Melchor Fernández Almagro, 3, 28029 Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain.

Álvaro Aceña (Á)

Department of Cardiology, IIS-Fundación Jiménez Díaz University Hospital-Quironsalud, Avenida Reyes Católicos, 2, 28040 Madrid, Spain.
Faculty of Medicine, Universidad Autónoma de Madrid, 28029 Madrid, Spain.

Classifications MeSH